Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Mounjaro every 5 days instead of every 7 is not part of the licensed dosing schedule. Tirzepatide is prescribed as a once-weekly injection, and that timing is built into how the medicine works, the way clinical trials were designed, and the safety profile regulators assessed. If you have found yourself wondering whether a shorter interval could do more, this page explains what the evidence says, what a narrowed gap actually risks, and what to do if your weekly schedule has slipped. These are prescription-only medicines; a clinician always decides the dosing plan that is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a reasonable thought. Mounjaro is a powerful medicine and it is tempting to wonder whether a tighter schedule would accelerate results. The 7-day interval, though, is not arbitrary. Tirzepatide has a half-life of approximately 5 days, meaning the concentration in your bloodstream is still measurable and active well into the following week. That pharmacokinetic profile is exactly why weekly dosing maintains a steady, overlapping level of the medicine between injections. Compressing the interval to 5 days would create a higher trough concentration than the clinical programme was designed around, and the SURMOUNT-1 trial (which recruited 2,539 adults and produced the efficacy and safety data regulators used to approve tirzepatide) ran on a strict once-weekly schedule throughout its 72 weeks.
In practical terms, injecting on day 5 instead of day 7 means layering a new dose on top of a level that has not fully followed the expected curve. The most likely consequence is a sharper rise in circulating drug, which could intensify gastrointestinal effects (nausea, vomiting, or diarrhoea) at a time when your body is not expecting a peak. There is no published evidence that the outcome is better weight loss. Our tirzepatide overview covers the pharmacology in more depth if you want the fuller picture.
The bottom line: the 5-day idea is understandable but it is not supported by the prescribing guidance, and the risks are real.
Life does intervene. A week away, a Friday bank holiday, a pen left in the car on a warm day — your injection day will occasionally move. The Mounjaro Summary of Product Characteristics and Patient Information Leaflet do address this, and the NHS tirzepatide patient page provides accessible guidance: if you miss a dose, take it as soon as you remember, provided it is within a set number of days of when it was due. After that window, skip it and continue on your normal day. The result is sometimes an interval that ends up shorter than 7 days, but that is different from deliberately planning to inject every 5 days as a routine.
Deliberate interval shortening as a strategy is a separate conversation, and it is one to have with your prescriber rather than manage unilaterally. If your usual day genuinely no longer works (perhaps your prescription arrives on a different day now, or your lifestyle has shifted) a prescriber can help you choose a new consistent day. What they would not recommend is a rolling 5-day cycle, which means your injection falls on a different day of the week each time and makes it harder to track your schedule safely.
Some people reading this will also be curious about other shortened intervals. The question of taking Mounjaro every 6 days is another common one, and much of the same reasoning applies.
Tirzepatide's titration schedule starts at 2.5 mg for the first four weeks, not because that dose delivers significant weight loss, but because it gives your system time to adjust before the prescriber considers moving up. Each step in the ladder (2.5 mg, 5 mg, 7.5 mg, and beyond) follows roughly four weeks at the current dose, and that spacing matters. Compressing the dose interval effectively means you are spending less time at each pharmacokinetic steady state before the next injection arrives.
The side effects most associated with GLP-1 and dual GIP/GLP-1 medicines are gastrointestinal: nausea, loose stools, reflux, and occasionally vomiting. These tend to peak in the first day or two after injection and ease by mid-week. Many people plan their injection day around this, Monday evening, say, so the worst of the nausea has passed before the week gets busy. Injecting on day 5 compresses that recovery window significantly. If you have concerns about side effects, the Mounjaro treatment page has a plain-English overview, and our prescribers are available seven days a week.
It is also worth knowing that any interaction concerns (for example, if you have been prescribed an antibiotic) should go straight to your clinical team. The question of clarithromycin and Mounjaro is one that our prescribers handle regularly, and it is the kind of detail that matters when you are adjusting anything about your regimen.
The right step is straightforward: contact your prescriber before you change anything. At nume (at our pharmacy) aftercare is available seven days a week precisely because questions like this arise between order cycles. You do not need to wait until your next review. A prescriber can look at your history, your current dose, and any symptoms you have been experiencing, and give you a specific answer for your situation.
If you are wondering whether a different interval might work better because your current results feel slow, that conversation is also worth having, but the answer is almost never to increase the frequency. It is more likely to involve reviewing whether you are at the right dose, whether lifestyle factors are playing a role, or whether a dose increase is clinically appropriate. Our FAQ page covers some of the most common questions about what to expect month by month.
For those researching other timing questions, we have also covered what happens when the gap extends rather than contracts: taking Mounjaro every 10 days is a different scenario with its own implications. And if cost is part of why you are rethinking your schedule (perhaps trying to stretch a pen further) our Mounjaro cost page explains what is included in a private prescription and how pricing actually works, which is a better starting point than adjusting your clinical plan. When you are ready to review your treatment with a clinician, you can speak to our prescribers at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.